Get Ready for Ugly as Markets Begin to Deal With Climate Crisis
Advocates of “market-based” climate solutions paint pastel pictures reflecting smoothly adjusting macro-economic models. Competitive markets gradually nudged by carbon pricing glide into a low carbon future in a modestly disruptive fashion, much as sulfur pollution from power plants was scaled back in the 1990’s.
But commodity markets for oil and gas don’t work that way. These real markets are poised to savagely strand assets, upset expectations, overturn long established livelihoods and leave a trail of wreckage behind them—unless climate advocates start owning the fruits of their own success and preparing for the transition. Schumpeter’s destructive engine of capitalism is about to show its ugly side.
Photo credit: Shutterstock
Two powerful forces are currently driving energy markets and climate outcomes.
Fossil fuel prices are indeed opening the door to climate solutions, but not through the gradual carbon pricing mechanisms so favored by economists (and recently, reluctantly beginning to be explored by conservative thinkers). Instead, the divergence between clean energy price curves, which fall rapidly with market share and fossil fuel prices, which rise with consumption, are about to collide explosively.
Second, Investors are indeed, moving away from fossil fuel stocks and bonds, but not out of ethical concern over climate risk, or even an expectation of global regulation of carbon combustion. They are racing to the exit as bloated coal and oil stock values collapse on the other side of the “Commodity Super-Cycle” which until early 2014 was the dominant paradigm.
Two weeks ago I wrote two pieces in Bloomberg Views suggesting that the fossil divestment movement was arguably behind market trends in arguing that coal and oil were bad investments. The following week witnessed a cascade of commentary making my pieces look milquetoast and timid. Markets are abandoning carbon companies—even if society continues to burn far too much of it.
Look at the numbers:
U.S. coal consumption has fallen, in the face of competition from performance (efficiency), alternatives (natural gas) and disrupters (solar and wind.) Five years ago we burned a billion tons of coal; now we burn 850 million tons. Solid progress. But still 850 million tons.
What happened to coal company share values? In the last five years, a coal company has gone bankrupt on the average every month. The second largest U.S. coal company, Alpha, after one bankruptcy and reorganization, was just dumped from the NY Stock Exchange because its price fell below $1.00. Even a coal producer (Walter) whose output, metallurgical coal, still enjoys a strong market had to file for bankruptcy. The biggest U.S. coal company, Peabody, which traded in 2011 at $73, is now selling at $1.29. The bond markets have abandoned coal. All coal company debt is now graded “junk.” In the last quarter the three worst performing major U.S. bonds were all coal:
Alpha Natural Resources: -70 percent
Peabody: -40 percent
Arch: -30 percent
Coal, as an investment class, is effectively finished—coal companies will go through a series of reorganizations. After each one only those with the best balance sheets and cheapest mines will remain. The reclamation bonds which the U.S. government and the State of Wyoming allowed these companies to self-insure against their balance sheets are about to go south, creating sequential calls on capital that will push even more companies first into Chapter 11 and then into Chapter 7. Outside the U.S., 1/6th of Australia’s coal mines now operate at a loss. Companies in the sector are in liquidation, even though the world will use a lot of coal for quite a while to come. Eventually slumping demand will be overtaken by declining production and more mines will become cash flow positive, but existing stakeholders will be liquidated first. That’s the dynamic of shrinking commodity markets—investors, communities and workers lose fast even as markets shrink slowly.
Many investors thought they could be the last to make a profit on conventional telephone land-lines. Someone was that last lucky bottom-feeder. But most of those who entertained that illusion were wiped out. Coal investors can join the line.
But what about oil and gas? The public—and politicians—still view oil as the necessary evil and oil companies as the essential usurers of our dependence. But the markets are not so sure. Since 2011 a "five-point gap has emerged between market valuations for energy companies and the S&P 500, as returns on capital have fallen in the sector.” Federal banking regulators have begun warning lenders that many of the loans made to drillers at the height of the shale rush must be treated as “substandard.”
BP recently earned the dubious distinction of being the first of IOC’s integrated majors to have its bonds de-rated because of potential environmental liabilities from the Deepwater Horizon Spill. Shell was able to finance one of its recent pipeline projects at 23 times its earnings, but its own shares fetch only 9X. From 2006 to 2013 the percentage of Exxon Mobil’s proven reserves made up of tar sands and heavy oil increased from 15 percent to 32 percent. Relying on a larger share of more expensive oil reduced Exxon Mobil's margins and returns. Its stock value trailed the S&P 500 by 40 percent during those seven years—even as the company used the vast majority of its profits to buy back shares to sustain their value.
Chatham House in a recent analysis commented, “Even before the 2014 oil price collapse, equity investors were concerned that, with few exceptions, many companies in the oil sector were heavily committed to high-cost projects for which they had a poor record of execution.”
Now, with oil less than half its price a year ago, companies are desperately canceling projects; a few months ago $118 billion in oil exploration and development projects had been shelved; this month Wood Mackenzie said the total had risen to $200 billion, a cut of almost 50 percent in investments to replace reserves. The biggest victims: not just U.S. shale producers, but Canadian tar sands, declining North Sea fields and Brazilian deep ocean drilling. Big investors have been hit hard: Carl Icahn and John Paulson have lost hundreds of millions of dollars on their oil bets.
Investor owned oil companies are particularly vulnerable in an oil commodity-cycle price crunch because while their existing reserves include large volumes of relatively cheap to pump legacy reserves, their ability to replace those reserves is highly constrained to the world’s most expensive ultra-deep, super-heavy and wildly remote reserves. “Even before the 2014 oil price collapse, equity investors were concerned that, with few exceptions, many companies in the oil sector were heavily committed to high-cost projects for which they had a poor record of execution.” The remaining untapped cheap or moderately costly oil fields are mostly off-limits to IOC’s, reserved by Russia, Venezuela and Persian Gulf monarchies for their nationally owned oil companies, whose long term business plan is to squeeze the Western IOC’s out of business.
In 1915, as the American economy boomed, the huge supply chain that supported horse-drawn transport—harnesses and horseshoes, wagons and buggies makers (13,000 of them), farriers and blacksmiths, hay balers and feedmills—looked like a robust and vital segment for deploying capital. 1920 was the year of “Peak Horse” in the U.S.. By 1940 it was gone. This was not “low-cost”, incremental progress. It was an economic disruption so fierce that the phrase “buggy-whip maker” became a business simile for loser.
From both the standpoint of barometric pressure and stock market volatility we have sown the winds of fossil fuel capitalism for a decade too long—but bemoaning that fact changes nothing. As Christina Figueres says “Better late than later.” We still have time to prepare for the whirlwind. It will come whether we prepare or not.
YOU MIGHT ALSO LIKE
EcoWatch Daily Newsletter
As protests are taking place across our nation in response to the killing of George Floyd, we want to acknowledge the importance of this protest and the Black Lives Matter movement. Over the years, we've aimed to be sensitive and prioritize stories that highlight the intersection between racial and environmental injustice. From our years of covering the environment, we know that too often marginalized communities around the world are disproportionately affected by environmental crises.
- Lead Poisoning Reveals Environmental Racism in the US - EcoWatch ›
- First-of-Its-Kind Study Finds Racial Gap Between Who Causes Air ... ›
- Pollution, Race and the Search for Justice - EcoWatch ›
By Peter Beech
Using waste food to farm insects as fish food and high-tech real-time water quality monitoring: innovations that could help change global aquaculture, were showcased at the World Economic Forum's Virtual Ocean Dialogues 2020.
Fly fishing. nextProtein
BiOceanOr's AquaREAL system. BiOceanOr
- Environmental Innovation Will Transform Business as Usual ... ›
- How an Army of Ocean Farmers Is Starting an Economic Revolution ... ›
The big three broadcast channels failed to cover the disproportionate impacts of extreme weather on low-income communities or communities of color during their primetime coverage of seven hurricanes and one tropical storm over three years, a Media Matters for America analysis revealed.
Researchers at the pharmaceutical giant Eli Lilly announced yesterday that it will start a trial on a new drug designed specifically for COVID-19, a milestone in the race to stop the infectious disease, according to STAT News.
- Dogs Can Smell COVID-19 - EcoWatch ›
- Drugs Touted by Trump for COVID-19 Increase Heart Risks, Studies ... ›
- Coronavirus Vaccine Candidate Shows Promise in Mice - EcoWatch ›
The sixth mass extinction is here, and it's speeding up.
Terrestrial vertebrates on the brink (i.e., with 1,000 or fewer individuals) include species such as (A) Sumatran rhino (Dicerorhinus sumatrensis; image credit: Rhett A. Butler [photographer]), (B) Clarion island wren (Troglodytes tanneri; image credit: Claudio Contreras Koob [photographer]), (C) Española Giant Tortoise (Chelonoidis hoodensis; image credit: G.C.), and (D) Harlequin frog (Atelopus varius; the population size of the species is unknown but it is estimated at less than 1,000; image credit: G.C.).
- Humanity 'Sleepwalking Towards the Edge of a Cliff': 60% of Earth's ... ›
- New Border Wall Construction Threatens 8 Species With Extinction ... ›
- The Insect Apocalypse Is Coming: Here Are 5 Lessons We Must Learn ›
By Cathy Cassata
With more than 1.7 million confirmed cases of COVID-19 in the United States and more than 100,000 deaths from the virus, physicians face unprecedented challenges in their efforts to keep Americans safe.
They also encounter what some call an "infodemic," an outbreak of misinformation that's making it more difficult to treat patients.
When Leaders and Doctors Spread Misinformation<p>When people in charge of towns, cities, states, and countries spread misinformation, the potential for belief in misinformation to result in policies can have harmful effects.</p><p><a href="https://www.northwell.edu/find-care/find-a-doctor?q=Bruce+E.+Hirsch%2C+MD&insurance=&location=&query_type=provider&physician_partners=false&default_view=list&gender=&language=&sort=relevancy" target="_blank">Dr. Bruce E. Hirsch</a>, attending physician and assistant professor in the infectious disease division of Northwell Health in Manhasset, New York, says an example of this is when President Trump informed the public he was taking hydroxychloroquine as a preventive measure.</p><p>"To approach this enormous challenge, we need some intellectual honesty and clarity, and to disregard expertise and to make decisions and model decisions based on hunches is inviting us to handle challenges on the basis of rumor and uninformed opinion. The magnitude of that error is epic," Hirsch told Healthline.</p><p>Stukus agrees, noting that the harm of this proclamation is documented.</p><p>"Early on when the president touted the benefits of hydroxychloroquine and azithromycin, people started to hoard this medicine, and state boards had to shut it down because they were getting so many prescriptions for this unproven therapy that it was not available for those who truly needed it, such as those who have lupus and autoimmune conditions," Stukus said.</p><p>He adds that calls to poison control centers increased after the president suggested using disinfectant to prevent contracting the new coronavirus.</p>
Listen to Science, Even When it Changes<p>When recommendations change or evidence flip-flops, skepticism may arise. However, Stukus says change is the beauty of science.</p><p>"That shows us that we can evolve, and if the evidence shows that our prior thoughts were incorrect, we need to be able to change our recommendations and advice based upon the best quality of evidence at the time," he said.</p><p>Pierre agrees.</p><p>"Science is an iterative process, whereby we arrive at facts and truth through repeated and controlled observations. That means that it's inherently self-correcting as we revise conclusions based on ongoing research. Scientific facts aren't immutable dogma chiseled on a tablet. They change based on the best available evidence we have at a given point in time," he said.</p><p>Because research of COVID-19 has only been underway for 6 months, information is evolving rapidly, and new information may contradict old.</p><p>"There's still much we don't know about exactly how [COVID-19] spreads, what effects it has on the body, or how to best treat it. That means that the best available evidence is preliminary, but that doesn't mean that we should ignore it or turn to other sources of information or opinion as if they're just as valid," Pierre said.</p><p>He explains that conspiracy theories based on mistrust lead to vulnerability to misinformation.</p><p>If people mistrust science because it sometimes "changes its mind," Pierre said, "that shouldn't be used to embrace other opinions based on no evidence at all, which are typically selected based on confirmation bias: what we want to believe rather than what the objective evidence supports."</p>
Where to Find the Best Information<p>Stukus says to start with the <a href="https://www.cdc.gov/coronavirus/2019-nCoV/index.html" target="_blank">CDC</a> and <a href="https://www.nih.gov/health-information/coronavirus" target="_blank">NIH</a>. Then check with your local health officials, because COVID-19 guidelines may vary depending on where you live.</p><p>If you can't find information you need or have questions specifically related to you, call your primary care doctor.</p><p>"Your personal doctor should always be a resource for individual specific questions because they know best how to apply all the nuances retaining to your health, and how to incorporate all the other general [COVID-19] recommendations," Stukus said.</p><p><a href="https://www.eehealth.org/find-a-doctor/b/boyd-laura-b/" target="_blank">Dr. Laura Boyd</a>, primary care physician at Edward-Elmhurst Health Center in Elmhurst, Illinois, says her clinic receives a lot of calls about COVID-19.</p><p>"Most doctors' offices are receiving calls and answering questions, and doing phone or video visits to help clarify and/or order testing over the phone based on patients' symptoms. It is always best to call your doctor's office first instead of worrying about symptoms and waiting too long to seek treatment," she told Healthline.</p><p>If your primary care doctor has limited testing, she suggests looking on your state's public health website for available testing sites.</p><p>With a lot of unknowns related to this virus and disease, Boyd says many patients are feeling overwhelmed and anxious for a treatment.</p><p>"Unfortunately, there is no specific medication recommended for COVID for outpatient. There are a lot of ongoing studies with various drugs going on within the hospital setting. Patients should always contact their doctors about their specific symptoms as they can treat the symptoms that go along with COVID, but there is no cure," Boyd said.</p><p>While we wait for treatment and a vaccine, Hirsch, who treats patients hospitalized for COVID-19 complications on a daily basis, says everyone can do their part by washing hands, wearing a mask, and staying 6 feet apart.</p><p>"As an infectious disease doctor working in the hospital, I see the damage of the pandemic and the worst cases of what's happening. We are trying to get the best possible outcome and confronting this overwhelming biologic reality of this terrible epidemic the best we can," Hirsch said.</p><p>Everyone at home can help in the fight too, he adds.</p><p>"Follow information that is science- and evidence-based, and avoid that which is not," he said.</p>
- WHO Declares Global Health Emergency as Coronavirus Cases ... ›
- Here's What We Know About Ibuprofen and COVID-19 - EcoWatch ›
- Trump's Budget Plan: A Push for Even Greater Environmental ... ›
- Trump Pushed for Mining Project That Could Destroy Alaska Salmon ... ›